API Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (Websockets) API Financial News API Delisted Data API
Solutions
New & Popular APIs
Show all APIs Fundamental Data APIs Historical End-of-Day API Real-time Prices API Financial Events & News API Indices Historical Constituents API 40 000 Stock Market Logos API Forex Data APIs
Other products
Google Sheets Add-on Excel Add-on Coding Libraries (Python, R, etc) Wordpress Add-on
API Marketplace
Community
Academy 152 articles Forum Github 14 repos
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NSE /
  3. CIPLA.NSE

Cipla Limited (CIPLA NSE) stock market data APIs

INR1495.9 -7.4(-0.5%) as of November 25, 2024
Price chart is built with Anychart

Cipla Limited, together with its subsidiaries, engages in the manufacture, development, sale, and distribution of pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New Ventures segments. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such as MI, angina, heart disease, pulmonary disease, kidney failure, Alzheimer's disease, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, central nervous system, HIV/AIDS, respiratory, asthma, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women's health, ophthalmology, and neuro psychiatry. The company is also involved in the consumer healthcare, biosimilars, and specialty businesses. Cipla Limited was incorporated in 1935 and is based in Mumbai, India.

Cipla Limited Financial Data Overview

1503.3
1495.9
-
1507.5
1487.5
1177.9974-1702.05
1 200 515 M
26.8079
808 M
262 642 M
16.12
0.0087
0.344
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'CIPLA',
Type: 'Common Stock',
Name: 'Cipla Limited',
Exchange: 'NSE',
CurrencyCode: 'INR',
CurrencyName: 'Indian Rupee',
CurrencySymbol: 'INR',
CountryName: 'India',
CountryISO: 'IN',
OpenFigi: NULL,
ISIN: 'INE059A01026',
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'March',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Drug Manufacturers - General',
}

Cipla Limited Fundamental Data is available in our Financial Data APIs

  • Net Revenue 262 642 M
  • EBITDA 65 644 M
  • Earnings Per Share 55.45
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Cipla Limited Earnings via APIs

  • Latest Release 2024-10-29
  • EPS/Forecast 14.95

Get Cipla Limited End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Cipla Limited latest news via APIs

Indian drugmaker Cipla beats Q1 profit view on strong demand; shares hit record high

By Kashish Tandon HYDERABAD/BENGALURU (Reuters) -Cipla, India's third-largest generics drugmaker by sales, beat first-quarter profit estimates on Friday as it reported higher sales in its North Ameri...

Indian drugmakers to see FY25 revenue boost in key US market, says India Ratings and Research

By Rishika Sadam HYDERABAD (Reuters) - Indian drugmakers, which have the U.S. market as a key segment, will sustain their revenue improvement in fiscal 2025 due to drug shortages in the United States...
News API is available at any package from $19.99 See full price
Get sample of News API
Do you have any questions?
support@eodhistoricaldata.com